Back

Posted by

Medicare in early 2026 did not pay for GLP-1 for obesity treatment, and coverage under Medicaid varied widely by state.

Findings

Additional insights we found via this resource

  1. Coverage for GLP-1s for obesity treatment is limited. Until July 2026, it was barred under Medicare (a new program covers it in some instances), and it was only covered under Medicaid in 13 states as of January 2026, since states can choose whether to cover weight-loss drugs under Medicaid. Coverage with private insurers also remains limited.

More Posts

You've reached the end.